ARK Genomic Revolution ETF (ARKG) 📈: графики для анализа доходности фонда ARK Genomic Revolution ETF

Kategorie	Aktie, %	Menge
Healthcare	97.05991	34

Austausch	Aktie, %	Menge
NASDAQ	94.12	32
New York Stock Exchange	5.88	2

Land	Menge	Unternehmen
United States	31	Twist Bioscience Corporation (aktie - 8.63%) Recursion Pharmaceuticals, Inc. (aktie - 6.46%) CareDx, Inc (aktie - 6.38%) Intellia Therapeutics, Inc. (aktie - 5.09%) Ionis Pharmaceuticals (aktie - 4.28%) Veracyte, Inc. (aktie - 4.27%) 10x Genomics, Inc. (aktie - 4.08%) Nurix Therapeutics, Inc. (aktie - 4%) Adaptive Biotechnologies Corporation (aktie - 3.91%) Beam Therapeutics Inc. (aktie - 3.63%) Natera, Inc. (aktie - 3.49%) Schrödinger, Inc. (aktie - 3.37%) Arcturus Therapeutics Holdings Inc. (aktie - 3.15%) Personalis, Inc. (aktie - 2.86%) Guardant Health, Inc. (aktie - 2.77%) Veeva Systems (aktie - 2.21%) Moderna (aktie - 1.98%) Amgen (aktie - 1.86%) Absci Corporation (aktie - 1.84%) Vertex (aktie - 1.79%) Pacific Biosciences of California, Inc. (aktie - 1.73%) Accolade, Inc. (aktie - 1.64%) Fluidigm Corporation (aktie - 1.33%) Regeneron (aktie - 1.26%) Butterfly Network, Inc. (aktie - 1.26%) Exact Sciences Corporation (aktie - 1.15%) Incyte (aktie - 1.01%) Cerus Corporation (aktie - 0.9926%) 908 Devices Inc. (aktie - 0.8681%) Quantum-Si incorporated (aktie - 0.8655%) Prime Medicine, Inc. (aktie - 0.8206%)
Switzerland	1	CRISPR Therapeutics AG (aktie - 6.42%)
United Kingdom	1	COMPASS Pathways plc (aktie - 1.07%)
Canada	1	Repare Therapeutics Inc. (aktie - 0.6085%)

Investing Port